Drug Information

Drug General Information
Drug ID
D06ORU
Former ID
DIB011567
Drug Name
Butacaine
Drug Type
Small molecular drug
Indication Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] Approved [551871]
Formula
C36H62N4O8S
Canonical SMILES
CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1
InChIKey
HQFWVSGBVLEQGA-UHFFFAOYSA-N
PubChem Compound ID
120185
Target and Pathway
Target(s) Sodium channel Target Info Modulator [550133], [551871]
KEGG Pathway Dopaminergic synapse
Reactome Interaction between L1 and Ankyrins
References
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 550133WO patent application no. 2008,0857,11, Synergy of sodium channel blockers and calcium channel blockers.
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.